Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NGX-4010 Dose Finding Study in Postherpetic Neuralgia
NCT00061776Phase 3Completed
- Sponsor
- NeurogesX
- Modality
- Transdermal Patches, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of capsaicin 8% patch in postherpetic neuralgia (PHN), sponsored by NeurogesX. Status: completed.
02
Drugs
capsaicin 8% patch
03
Conditions
postherpetic neuralgia (PHN)
Beyond the preview
Go deeper on NCT00061776.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00061776.